BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21874222)

  • 21. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.
    Savry A; Carre M; Berges R; Rovini A; Pobel I; Chacon C; Braguer D; Bourgarel-Rey V
    Neoplasia; 2013 Jan; 15(1):49-60. PubMed ID: 23358890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect and mechanism of vinorelbine on cisplatin resistance of human lung cancer cell line A549/DDP].
    Qi C; Gao S; Li H; Gao W
    Zhongguo Fei Ai Za Zhi; 2014 Feb; 17(2):148-54. PubMed ID: 24581167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice].
    Dai M; Luo RC; Zheng DY; Lü CW; Ding XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Feng B; Huang GC; Wang R; Chen LB; De W
    Mol Cancer Res; 2013 Jul; 11(7):699-713. PubMed ID: 23562878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The study of effect and mechanism of 630-nm laser on human lung adenocarcinoma cell xenograft model in nude mice mediated by hematoporphyrin derivatives.
    Lin C; Zhang Y; Wang J; Sui A; Xiu L; Zhu X
    Lasers Med Sci; 2020 Jul; 35(5):1085-1094. PubMed ID: 31642999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine).
    Adams DJ; Knick VC
    Invest New Drugs; 1995; 13(1):13-21. PubMed ID: 7499103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effect of a copper (II) complex of a coumarin derivative and phenanthroline on lung adenocarcinoma cells and the mechanism of action.
    Zhu T; Chen R; Yu H; Feng Y; Chen J; Lu Q; Xie J; Ding W; Ma T
    Mol Med Rep; 2014 Nov; 10(5):2477-82. PubMed ID: 25176185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and significance of clusterin in Anip973/NVB cell lines.].
    Liu W; Cai L; Ning J; Li D
    Zhongguo Fei Ai Za Zhi; 2008 Oct; 11(5):696-9. PubMed ID: 20738915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice.
    Tsuruo T; Inaba M; Tashiro T; Yamori T; Ohnishi Y; Ashizawa T; Sakai T; Kobayashi S; Gomi K
    Anticancer Drugs; 1994 Dec; 5(6):634-40. PubMed ID: 7888700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.
    Hu Y; Qin X; Yan D; Cao H; Zhou L; Fan F; Zang J; Ni J; Xu X; Sha H; Liu S; Yu S; Wu J; Ma R; Feng J
    Tumour Biol; 2017 Mar; 39(3):1010428317691659. PubMed ID: 28345454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
    Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
    Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.
    Zhang D; Ochi N; Takigawa N; Tanimoto Y; Chen Y; Ichihara E; Hotta K; Tabata M; Tanimoto M; Kiura K
    Cancer Lett; 2011 Oct; 309(2):228-35. PubMed ID: 21742432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.
    Xu L; Fu Y; Li Y; Han X
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):235-242. PubMed ID: 28597042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
    Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PERP gene therapy attenuates lung cancer xenograft via inducing apoptosis and suppressing VEGF.
    Chen K; Luo Z; Li Z; Liu Y; Zhao Q
    Cancer Biol Ther; 2011 Dec; 12(12):1114-9. PubMed ID: 22236877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.
    Zou M; Xia S; Zhuang L; Han N; Chu Q; Chao T; Peng P; Chen Y; Gui Q; Yu S
    Int J Oncol; 2013 Jun; 42(6):2094-102. PubMed ID: 23588221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.